A5049774278- Ovarian function and disorders
- Reproductive Biology and Fertility
- Assisted Reproductive Technology and Twin Pregnancy
- Reproductive Health and Technologies
- Reproductive System and Pregnancy
- Ectopic Pregnancy Diagnosis and Management
- Sperm and Testicular Function
- Endometriosis Research and Treatment
- Prenatal Screening and Diagnostics
- Gynecological conditions and treatments
- Sexual Differentiation and Disorders
- Pregnancy and preeclampsia studies
- Ovarian cancer diagnosis and treatment
- Hypothalamic control of reproductive hormones
- Reproductive Health and Contraception
- Birth, Development, and Health
- Thyroid Disorders and Treatments
- Renal and related cancers
- Uterine Myomas and Treatments
- Reproductive Physiology in Livestock
- Pregnancy and Medication Impact
- Hormonal and reproductive studies
- Thyroid Cancer Diagnosis and Treatment
- Growth Hormone and Insulin-like Growth Factors
- Gestational Diabetes Research and Management
Aristotle University of Thessaloniki
2016-2025
Papageorgiou General Hospital
2016-2025
UNSW Sydney
2025
EES Research (United Kingdom)
2019
Science Club
2019
Universitair Ziekenhuis Brussel
2002-2011
Vrije Universiteit Brussel
2002-2007
French Community of Belgium
2005-2007
Weatherford College
2006
University Hospital of Ioannina
2004
Single-embryo transfer has been recommended to reduce the incidence of multiple gestations when in vitro fertilization is performed women under 36 years age. We designed a prospective, randomized, controlled trial determine whether there were any differences rates pregnancy and delivery between undergoing single cleavage-stage (day 3) embryo those blastocyst-stage 5) embryo.We studied 351 infertile age who randomly assigned undergo either (176 patients) or (175 patients). Multifollicular...
Abstract STUDY QUESTION What is the recommended management of ovarian stimulation, based on best available evidence in literature? SUMMARY ANSWER The guideline development group formulated 84 recommendations answering 18 key questions stimulation. WHAT IS KNOWN ALREADY Ovarian stimulation for IVF/ICSI has been discussed briefly National Institute Health and Care Excellence fertility problems, Royal Australian New Zealand College Obstetricians Gynaecologist published a statement assisted...
BACKGROUND: Eliciting an endogenous LH surge by GnRH-agonist for the induction of final oocyte maturation may be more physiological compared with administration HCG. However, efficacy this intervention in patients treated IVF GnRH antagonists remains to assessed. METHODS: 106 were randomized receive either 10 000 IU urinary HCG or 0.2 mg Triptorelin triggering maturation. Ovarian stimulation was performed a fixed dose 200 recombinant FSH and antagonist started on day 6. Luteal phase...
Women with polycystic ovary syndrome (PCOS) are at risk of developing ovarian hyperstimulation (OHSS) during stimulation. Use GnRH antagonist in the general subfertile population is associated lower incidence OHSS than agonists and similar probability live birth but it unclear if this true for patients PCOS. Our aim was to compare flexible agonist long protocols PCOS undergoing IVF (primary end-point: ongoing pregnancy rate per patient randomized). In randomised controlled trial (RCT), 220...
STUDY QUESTIONWhat is the proper way of assessing effect progesterone elevation (PE) on day hCG live birth in women undergoing fresh embryo transfer after vitro fertilization (IVF) using GnRH analogues and gonadotrophins?